REPEAT – TAAT™ Now Sold in Over 2,500 Retail Stores in the United States
As of March 2022, TAAT™ Global Alternatives Inc. (OTCQX: TOBAF) has expanded its retail presence to over 2,500 stores in the U.S., averaging 45 new stores per week. This growth follows the company's initial launch in December 2020, when it first entered retail. TAAT™'s tobacco-free and nicotine-free products are positioned favorably against traditional tobacco cigarettes, benefitting retailers with better profit margins. The company's direct-to-consumer sales through the TryTAAT platform further enhance market reach and consumer access.
- Increased retail presence to over 2,500 stores in the U.S.
- Average of 45 new store additions per week in 2022.
- Retailers reportedly earn higher profit margins from TAAT™ compared to traditional cigarettes.
- None.
LAS VEGAS and VANCOUVER, British Columbia, March 23, 2022 (GLOBE NEWSWIRE) -- TAAT™ GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT™”) is pleased to announce that as of the third week of March 2022 more than 2,500 retail stores in the United States are carrying TAAT™ Original, Smooth, and Menthol. In its January 11, 2022 press release, the Company announced that its U.S. store count had surpassed 2,000 within approximately one year of launching TAAT™ at retail in Ohio in late December 2020. Based on this recent performance, the Company has added an average of approximately 45 new U.S. stores per week in 2022. TAAT™ continues to leverage its network of distributors to further expand its store count and cultivate a strong presence at the point of sale to encourage first-time and repeat purchases of TAAT™ products in place of tobacco cigarettes.
For clarity, the current U.S. store count of at least 2,500 TAAT™ retailers does not include establishments that have purchased TAAT™ on a wholesale basis through channels that do not supply retailer account data (e.g., select distributors who choose not to report such information, “cash-and-carry” warehouses that do not capture purchaser details). As such, the Company’s overall footprint in the United States is believed to be larger than the 2,500 stores confirmed as of this week. Furthermore, in addition to brick-and-mortar retailing, the Company also distributes TAAT™ directly to consumers through its TryTAAT e-commerce platform, allowing the majority of smokers in the U.S. to order TAAT™ for home delivery. Through parallel marketing initiatives such as TAAT™ billboards being placed in select markets, TAAT™ is seeking to fortify macro-level awareness of its brand to further establish itself in the mainstream range of tobacco product offerings.
A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/6e28955d-d02e-43fb-b1d7-17cce39ed394
Readers using news aggregation services may be unable to view the media above. Please access SEDAR or the Investor Relations section of the Company’s website for a version of this press release containing all published media.
TAAT™ Founder Joe Deighan commented, “Now that we are a proven brand in the tobacco category, retailers are far more willing to carry TAAT™ in their stores, maintain an ample supply (i.e., more than a test inventory of a few packs), and place TAAT™ in high-visibility spots for consumers to see. Although products such as TAAT™ are fairly easy to place in independent smoke shops, there are more nuances when it comes to building a presence in the convenience category, which is where the bulk of smokable products are sold. Our commercialization strategies have therefore focused on appealing to the buyers and merchandisers in the convenience channel, who understand how TAAT™ is optimally positioned relative to legacy tobacco cigarette offerings. With consumers continuing to walk into stores across the country looking for TAAT™, retailers are recognizing that it is important for our product to be placed in a prime space on their cigarette display racks. This is not just to give the customers what they want, it’s also because our retailers make significantly better profit margins on TAAT™ than they do on packs of tobacco cigarettes such as Marlboro. That is, they have a financial incentive to convert their clientele to TAAT™ because doing so will be significantly more lucrative for them in the long run. By offering a win-win all around for wholesalers, retailers, and consumers alike, TAAT™ has enjoyed continued growth of its market share as an innovative provider of a better choice for current smokers.”
On behalf of the Board of Directors of the Company,
TAAT™ GLOBAL ALTERNATIVES INC.
“Setti Coscarella”
Setti Coscarella, CEO and Director
For further information, please contact:
TAAT™ Investor Relations
1-833-TAAT-USA (1-833-822-8872)
investor@taatglobal.com
THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.
About TAAT™ Global Alternatives Inc.
The Company has developed TAAT™, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in "Original", "Smooth", and "Menthol" varieties. TAAT™'s base material is Beyond Tobacco™, a proprietary blend which undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with "Big Tobacco" pedigree, TAAT™ was launched first in the United States in Q4 2020 as the Company seeks to position itself in the
For more information, please visit http://taatglobal.com.
References
1 Statista: Consumer Markets - Tobacco Products
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding the anticipated performance of TAAT™ in the tobacco industry, in addition to the following: Sustained presence of TAAT™ in retail stores in the United States, continued growth of the Company’s retail footprint. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the tobacco markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.
The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.
This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.
Statement Regarding Third-Party Investor Relations Firms
Disclosures relating to investor relations firms retained by TAAT™ Global Alternatives Inc. can be found under the Company's profile on http://sedar.com.
FAQ
What is the current U.S. store count for TAAT™ products as of March 2022?
How has TAAT™ expanded its retail presence in 2022?
What are the product offerings of TAAT™ Global Alternatives?
How does TAAT™ benefit retailers compared to traditional tobacco products?
What marketing strategies is TAAT™ employing to increase brand awareness?
